NDUFA13

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 · Q9P0J0 · NDUFA13 on Sugi Atlas →

757 patent compounds predicted against NDUFA13, 421 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL15258558	0.76	8/20
R-(+)-Marmin (SCHEMBL27804600)	0.83	7/20
R-(+)-Marmin (SCHEMBL29353819)	0.83	7/20
R-(+)-Marmin (SCHEMBL29625637)	0.83	7/20
SCHEMBL12362713	0.77	7/20
SCHEMBL15080621	0.77	7/20
SCHEMBL12362702	0.73	7/20
SCHEMBL31179835	0.59	7/20
SCHEMBL31397586	0.53	7/20
SCHEMBL31000416	0.78	6/20
SCHEMBL12362734	0.60	6/20
SCHEMBL13973668	0.47	6/20
SCHEMBL16316892	0.47	6/20
Auraptene (SCHEMBL2535029)	1.00	5/20
Auraptene (SCHEMBL2535034)	1.00	5/20
Umbelliprenin (SCHEMBL18265478)	0.98	5/20
Umbelliprenin (SCHEMBL26641528)	0.98	5/20
Umbelliprenin (SCHEMBL28133292)	0.98	5/20
SCHEMBL29999425	0.83	5/20
SCHEMBL24700226	0.81	5/20

Clinical trials — most relevant to NDUFA13 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease	PHASE3	COMPLETED
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease	PHASE3	COMPLETED
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)	PHASE3	WITHDRAWN
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	PHASE2	WITHDRAWN
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	PHASE2	RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy	PHASE2	COMPLETED
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy	PHASE2	ACTIVE_NOT_RECRUITING
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)	PHASE1/PHASE2	NOT_YET_RECRUITING
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease	PHASE2	COMPLETED
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?	PHASE1	UNKNOWN
A Pilot Study to Examine the Effects of Vitamin D Supplementation on Mitochondrial Bioenergetics in Older Adults	EARLY_PHASE1	COMPLETED
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine	nan	COMPLETED
The Natural History of Mitochondrial Diseases	nan	RECRUITING
Tissue Sample Study for Mitochondrial Disorders	nan	ENROLLING_BY_INVITATION
Nicotinamide Riboside and Mitochondrial Biogenesis	nan	COMPLETED
Natural History in Primary Mitochondrial Myopathies	nan	RECRUITING
Diagnostic Odyssey Survey 2	nan	COMPLETED
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases	nan	RECRUITING
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	nan	RECRUITING
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes	nan	NOT_YET_RECRUITING
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection	nan	COMPLETED
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.	nan	UNKNOWN
EPI-743 for Mitochondrial Respiratory Chain Diseases	nan	NO_LONGER_AVAILABLE
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip	nan	COMPLETED
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction	nan	COMPLETED
The International Registry for Leigh Syndrome	nan	RECRUITING
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders	nan	COMPLETED
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity	nan	RECRUITING
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance	nan	COMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a NDUFA13 binder may also engage these)

Protein	Name	Similarity
Q0MQ89	—	1.000	Q0MQ89 →
Q0MQ90	—	1.000	Q0MQ90 →
Q0MQ88	—	1.000	Q0MQ88 →
Q8RWA7	—	0.996	Q8RWA7 →
Q9ERS2	—	0.996	Q9ERS2 →
Q95KV7	—	0.994	Q95KV7 →
O49313	—	0.994	O49313 →
Q4R6H1	—	0.991	Q4R6H1 →
P47081	—	0.984	P47081 →
Q6FW43	—	0.982	Q6FW43 →
COX6C	Cytochrome c oxidase subunit 6C	0.982	landscape →
Q2PIY2	—	0.981	Q2PIY2 →
Q7YRJ9	—	0.981	Q7YRJ9 →
Q6BY05	—	0.981	Q6BY05 →
Q75FA7	—	0.981	Q75FA7 →
P0CB94	—	0.981	P0CB94 →
Q7YRK3	—	0.981	Q7YRK3 →
Q02380	—	0.980	Q02380 →
Q0MQE1	—	0.980	Q0MQE1 →
Q3UIU2	—	0.980	Q3UIU2 →
Q02854	—	0.980	Q02854 →
NDUFB6	NADH-ubiquinone oxidoreductase B17 subunit	0.980	landscape →
Q5AXJ9	—	0.980	Q5AXJ9 →
Q7YRK2	—	0.979	Q7YRK2 →
P42117	—	0.979	P42117 →
Q5R7J0	—	0.978	Q5R7J0 →
P11950	—	0.978	P11950 →
P80977	—	0.978	P80977 →
Q6CCF6	—	0.978	Q6CCF6 →
Q6CK73	—	0.978	Q6CK73 →